We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Individualized Prediction of Migraine Attacks Using a Mobile Phone App and Fitbit (Migraine Alert)

This study is currently recruiting participants.
Verified October 2017 by Second Opinion Health
Sponsor:
ClinicalTrials.gov Identifier:
NCT02910921
First Posted: September 22, 2016
Last Update Posted: November 1, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
Mayo Clinic
University of Southern California
Allergan
Information provided by (Responsible Party):
Second Opinion Health
  Purpose

This trial is collaboration between Mayo Clinic, Second Opinion Health (Simon Bloch, simon@somobilehealth.com 408-981-3814) and Allergan. Mayo Clinic investigators are conducting the clinical trial, Second Opinion Health is providing the software for use in the trial (Migraine Alert app for data collection, analysis and machine learning algorithms), and Allergan is providing funding.

The investigators hypothesize that the use of a mobile phone app and Fitbit wearable to collect daily headache diary data, exposure/trigger data and physiologic data will predict the occurrence of migraine attacks with high accuracy. The objective of the trial is to assess the ability to use daily exposure/trigger and symptom data, as well as physiologic data (collected by Fitbit) to create individual predictive migraine models to accurately predict migraine attacks in individual patients via a mobile phone app.


Condition
Migraine Disorders Headache Disorders, Primary Headache Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Individualized Prediction of Migraine Attacks Using a Mobile Phone App

Resource links provided by NLM:


Further study details as provided by Second Opinion Health:

Primary Outcome Measures:
  • AUC of individual prediction models using cross validation data on environmental and physiological variables. [ Time Frame: 10 weeks ]
    The study will develop a separate predictive model for each participant that will forecast probability of experiencing a migraine attack during a particular interval. The outcome measures performance of this model using the Area Under the Curve (AUC) metric. AUC measures how often the algorithm predicts a higher probability for a migraine over non-migraine. This measure is attractive because it is independent of the quantization threshold, which is required for other metrices such as precision/recall. In the baseline phase, 30% of the data will be randomly selected for cross validation and will not used for training the model. Once the model is trained, the AUC of the model is measured on the cross validation data as the outcome of this phase. The data will include various measurements of weather such as temperature, pressure, humidity, wind and physiological measurements such as sleep duration and quality and activity level measured through a wearable Fitbit device.

  • AUC of individual prediction models using post prediction data on environmental and physiological variables. [ Time Frame: 10 weeks ]
    The metric and the type of the data is the same as in Outcome 1. The only difference is that the data is obtained from the user after the model is trained. The user is not shown the prediction to avoid expectancy bias.


Estimated Enrollment: 30
Study Start Date: November 2016
Estimated Study Completion Date: February 2018
Estimated Primary Completion Date: January 2018 (Final data collection date for primary outcome measure)
Detailed Description:

Eliminating migraine attacks before they start is of an enormous importance to migraine sufferers. But figuring out the onset of an attack before it actually starts remains a major challenge for the medical community.

The widespread use of mobile smartphones, the availability of wearable devices that measure health information, and advances in multivariate pattern analysis via machine learning algorithms allow for development of individual predictive models that can determine the likelihood of an individual patient developing a migraine on a given day. Such models are based upon objectively measured biometric parameters (e.g. activity, sleep), objectively measured environmental conditions (e.g. weather parameters), exposures to possible migraine triggers, and patient reported symptoms. Using machine-learning algorithms to explore this large dataset that is collected for each patient, the optimal combination of factors that most accurately predict the likelihood of a migraine attack is determined.

Prediction of individual migraine attacks would have substantial positive impacts for patients with migraine. Accurate prediction of a migraine attack would give the migraineur a greater sense of control over their condition, a sense of control that is often lacking in patients with migraine. Most importantly, if individual migraine attacks could be predicted with high accuracy, treatment of that inevitable migraine attack before development of symptoms could prevent the attack altogether.

Eligible subjects will enter a baseline phase during which subjects will wear a Fitbit device and record data into the daily headache diary using the mobile phone app. This phase will be of variable duration for each subject to a maximum of 75 days. It is during the baseline phase that the individualized predictive model for a migraine attack is developed and optimized.

During the second phase (75 days), the accuracy of the predictive model will be tested. The probability of developing a migraine will be calculated and the accuracy of the prediction will be tested against the patient reported incidence of migraine attacks within the mobile phone app. Subjects will be blinded to the app's migraine attack predictions to avoid expectancy bias.

Migraine prediction suffers from 'the curse of dimensionality' (machine learning parlance). Too many factors affect outcomes, but the outcomes (positive migraine attacks) are few and far in between. To develop an accurate machine learning model using traditional approaches requires a long and impractical time duration. Migraine Alert has effectively addressed these using proprietary algorithms and techniques that generate individual models using fewer migraines. Covariate analysis is performed for each individual using features derived from the raw data. Individual models may differ from one other in the specific feature they use and/or the importance attached to them in the model. Proprietary techniques are used to create these individual models and to monitor their pre-validation and post-validation accuracy and recall. Concept drift as evidenced by any degradation in accuracy or recall is monitored in the prediction phase and model is retrained as necessary.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
People with episodic migraines
Criteria

Inclusion Criteria:

  • Subjects fulfilling ICHD-3beta criteria for migraine with average of 5 - 10 migraine attacks per month and up to 12 headache days per month
  • Males of females 18 years of age or older
  • Subject report of weather being one of the triggers
  • Subject has an iPhone
  • Subject is willing to wear a Fitbit device for the duration of the study
  • Subject has an active Facebook account or is willing to create one

Exclusion Criteria:

  • Children younger than 18 years of age
  • Subjects with headaches other than migraine or probable migraine
  • Inability to provide informed consent
  • Not willing to maintain a daily diary
  • Current participation in another clinical trial
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02910921


Contacts
Contact: Joy Few 480-342-2131 few.joy@mayo.edu

Locations
United States, Arizona
Mayo Clinic Arizona Recruiting
Scottsdale, Arizona, United States, 852589
Contact: Joy Few    480-342-2131    Few.Joy@mayo.edu   
Contact: Saran Vaughn, MD    480-342-6487    Vaughn.saran@mayo.edu   
Principal Investigator: Rashmi Halker Singh, MD         
United States, California
University of Southern California Recruiting
Los Angeles, California, United States, 90033
Contact: Ram Koppula, MD    323-442-5710    rk_198@usc.edu   
Principal Investigator: Soma Sahai-Srivastava, MD         
Sponsors and Collaborators
Second Opinion Health
Mayo Clinic
University of Southern California
Allergan
Investigators
Principal Investigator: Rashmi Halker Singh, MD Mayo Clinic
Principal Investigator: Soma Sahai-Srivastava, MD University of Southern California
  More Information

Additional Information:
Responsible Party: Second Opinion Health
ClinicalTrials.gov Identifier: NCT02910921     History of Changes
Other Study ID Numbers: 16-005803
First Submitted: September 13, 2016
First Posted: September 22, 2016
Last Update Posted: November 1, 2017
Last Verified: October 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by Second Opinion Health:
Migraine
Prediction
Forecast
App
Fitbit
Individual
Algorithm
Machine Learning
Mayo Clinic
Allergan
Second Opinion

Additional relevant MeSH terms:
Disease
Migraine Disorders
Headache
Nervous System Diseases
Brain Diseases
Central Nervous System Diseases
Headache Disorders
Headache Disorders, Primary
Pathologic Processes
Pain
Neurologic Manifestations
Signs and Symptoms